Movers

Arista Networks Names New COO, Experience At Fastly, Cisco Systems

Posted on: Tuesday, June 17, 2025 - 11:52am

CEO of Arista Networks, Todd Nightingale, will take over as President and COO in July 2025. Analyst maintains Overweight rating and praises his experience.

All terms: Analyst Color, Reiteration, Analyst Ratings, Movers

Why Is Dyne Therapeutics Stock Trading Lower On Tuesday?

Posted on: Tuesday, June 17, 2025 - 10:56am

Dyne updates DYNE-101 trial timeline, reports strong 12-month data, and receives FDA Breakthrough Therapy status for treating DM1.

All terms: Biotech, News, Health Care, FDA, Top Stories, Movers, General

AbbVie's Cancer Drug Venetoclax Falls Short In Phase 3 Combination Trial For Myelodysplastic Syndromes

Posted on: Tuesday, June 17, 2025 - 10:43am

AbbVie's Phase 3 VERONA trial in HR-MDS showed no overall survival benefit for venetoclax-azacitidine; existing uses of venetoclax remain unchanged.

All terms: Biotech, Large Cap, News, Health Care, Top Stories, Movers, General

Kirkland's Bets On The Brand House Collective For Turnaround After Q1 Loss

Posted on: Tuesday, June 17, 2025 - 10:21am

Kirkland-Photo by JHVEPhoto via Shutterstock

Kirkland's shares drop 14% after Q1 earnings miss and weak e-commerce results, as the company kicks off a major rebrand to The Brand House Collective.

All terms: Earnings, Equities, News, Top Stories, Markets, Movers, General

Oklo Stock Is Rising Again: What's Going On?

Posted on: Tuesday, June 17, 2025 - 10:14am

Oklo Inc (NYSE:OKLO) shares are trading higher Tuesday after the company announced subsidiary Atomic Alchemy commenced site characterization work at a potential location for a commercial radioisotope production facility.

All terms: News, Movers

What's Going On With Cero Therapeutics Stock Tuesday?

Posted on: Tuesday, June 17, 2025 - 10:03am

CERo Therapeutics Holdings Inc (NASDAQ:CERO) shares are trading higher Tuesday after the company received U.S. Food and Drug Administration (FDA) Orphan Drug Designation for CER-1236.

All terms: News, Movers

Mineralys Therapeutics: Investigational Drug Shows Benefit In Hypertensive Patients With Chronic Kidney Disease, Stock Jumps

Posted on: Tuesday, June 17, 2025 - 9:57am

Mineralys reports Phase 2 trial success for lorundrostat, showing BP and kidney improvements in CKD patients with favorable safety results.

All terms: Biotech, News, Health Care, Movers, Trading Ideas

Surgery Partners Rejects Bain Capital's Private Buyout Offer, Will Remain Independent

Posted on: Tuesday, June 17, 2025 - 9:47am

Surgery Partners rejects Bain Capital's acquisition bid, citing greater long-term value as a public company with strong growth potential and strategic plans.

All terms: News, Health Care, Movers, Trading Ideas

Jabil Raises Sales And Profit Outlook, Announces $500 Million Investment To Expand Footprint

Posted on: Tuesday, June 17, 2025 - 9:14am

Jabil Inc. (NYSE: JBL) reported strong third-quarter results, exceeding expectations for earnings and sales. It also announced plans for a $500 million investment to expand its presence in the Southeast US to support cloud and AI data center customers.

All terms: Earnings, News, Guidance, Top Stories, Movers, Tech

Leading And Lagging Sectors For June 17, 2025

Posted on: Tuesday, June 17, 2025 - 9:10am

All terms: Sector ETFs, Pre-Market Outlook, Movers, ETFs